TrialBlood advances2026
Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.
Hanny Al-Samkari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it